A股異動 | 獲券商唱好 青松股份(300132.SZ)一度大漲11%
格隆匯7月23日丨青松股份(300132.SZ)盤初一度大漲11%,現漲幅回落至4.4%,報19.78元,成交額超3億元,總市值102億元。

青松股份22日發佈公吿,李勇先生因個人原因辭去公司董事長、董事、總裁等一切職務,副總裁、諾斯貝爾創始人之一範展華代行董事長職責。國金證券指出,諾斯貝爾創始人代行董事長對公司管控加強,期待其正式入主董事局,該行長期看好本土化粧品加工龍頭髮展。維持 “買入”評級;廣發證券預計未來公司將集中力量全面發展化粧品業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.